HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Vasconsuelo, A. Articles by Boland, R. PubMed PubMed Citation Articles by Vasconsuelo, A. Articles by Boland, R.

Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur, San Juan 670, 8000 Bahía Blanca, Argentina

(Correspondence should be addressed to R Boland; Email: rboland{at}criba.edu.ar)

Estrogens can regulate apoptosis in various cellular systems. The present study shows that 17β-estradiol (E₂), at physiological concentrations, abrogates DNA damage, poly (ADP-ribose) polymerase cleavage, and mitochondrial cytochrome c release induced by H₂O₂ or etoposide in mouse skeletal muscle C2C12 cells. This protective action, which involved PI3K/Akt activation and Bcl-2 associated death agonist (BAD) phosphorylation, was inhibited by antibodies against the estrogen receptor (ER) or β isoforms, or transfecting siRNA specific for each isoform. The inhibition of the antiapoptotic action of E₂ at the mitochondrial level was more pronounced when ER-β was immunoneutralized or suppressed by mRNA silencing, whereas transfection of C2C12 cells with either ER- siRNA or ER-β siRNA blocked the activation of Akt by E₂, suggesting differential involvement of ER isoforms depending on the step of the apoptotic/survival pathway evaluated. These results indicate that E₂ exerts antiapoptotic effects in skeletal muscle cells which are mediated by ER-β and ER- and involve the PI3K/Akt pathway.